Shanghai Yizhong Pharmaceutical Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: -0.44x

Shanghai Yizhong Pharmaceutical Co Ltd free cash flow generation index. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Free Cash Flow Generation Index of -0.44x as of September 2025. Free cash flow of CN¥-9.33 Million represents 0% of operating cash flow (CN¥21.03 Million). Check asset resilience ratio of Shanghai Yizhong Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

-0.44x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-9.33 Million
CNY

Operating Cash Flow

CN¥21.03 Million
CNY

Capital Expenditures

CN¥30.36 Million
CNY

Free Cash Flow Generation Index of Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)

Free cash flow generation index of Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. Historical FCF Generation Index trend for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Explore Shanghai Yizhong Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Shanghai Yizhong Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2022–2024)

Shanghai Yizhong Pharmaceutical Co Ltd free cash flow generation index by year from 2022 to 2024. Year-by-year Free Cash Flow Generation Index for Shanghai Yizhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Shanghai Yizhong Pharmaceutical Co Ltd generate cash.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -1.03x CN¥-40.60 Million CN¥39.44 Million CN¥80.04 Million ▼ -214.6%
2023 0.90x CN¥77.77 Million CN¥86.55 Million CN¥8.78 Million ▲ +32.9%
2022 0.68x CN¥74.90 Million CN¥110.78 Million CN¥35.88 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).